Shenzhen Kangtai Biological Products Co., Ltd. (SHE:300601)

SHE:300601 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	14,174	16,497	19,155	30,324	27,232	67,700
Market Cap Growth	-28.39%	-13.88%	-36.83%	11.35%	-59.77%	-43.30%
Enterprise Value	14,220	16,717	20,961	31,692	28,013	65,942
Last Close Price	12.69	14.73	16.99	26.59	30.69	59.13

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
PE Ratio	182.70	234.57	94.99	35.21	-	53.59
Forward PE	81.14	70.60	20.24	22.39	22.73	50.97
PS Ratio	5.33	6.17	7.22	8.72	8.63	18.54
PB Ratio	1.47	1.71	1.98	3.18	3.03	7.39
P/TBV Ratio	1.55	1.80	2.08	3.33	3.16	7.68
P/FCF Ratio	57.71	54.33	146.15	96.37	-	-
P/OCF Ratio	24.33	25.96	31.75	29.35	49.90	40.97
PEG Ratio	-	1.56	0.52	0.99	0.99	0.96

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
EV/Sales Ratio	5.35	6.25	7.91	9.11	8.87	18.06
EV/EBITDA Ratio	32.38	38.42	46.87	32.35	68.98	38.68
EV/EBIT Ratio	-	403.37	161.26	40.72	136.56	50.71
EV/FCF Ratio	57.90	55.06	159.93	100.72	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Debt / Equity Ratio	0.20	0.20	0.21	0.26	0.26	0.30
Debt / EBITDA Ratio	4.39	4.34	4.52	2.52	5.64	1.61
Debt / FCF Ratio	7.85	6.21	15.44	7.83	-	-
Net Debt / Equity Ratio	0.01	-0.08	-0.06	0.07	0.03	-0.17
Net Debt / EBITDA Ratio	0.11	-1.78	-1.30	0.72	0.74	-0.90
Net Debt / FCF Ratio	0.19	-2.55	-4.45	2.24	-0.39	1.73
Asset Turnover	0.19	0.19	0.18	0.24	0.23	0.31
Inventory Turnover	1.15	1.10	0.90	0.87	0.87	1.54
Quick Ratio	2.24	2.37	2.04	1.66	1.84	2.35
Current Ratio	2.87	2.71	2.36	1.96	2.21	2.80
Return on Equity (ROE)	0.84%	0.73%	2.10%	9.30%	-1.46%	15.19%
Return on Assets (ROA)	0.12%	0.18%	0.55%	3.37%	0.92%	6.85%
Return on Invested Capital (ROIC)	0.28%	0.46%	1.34%	7.30%	2.43%	18.79%
Return on Capital Employed (ROCE)	0.20%	0.30%	1.10%	6.30%	1.80%	11.30%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Earnings Yield	0.57%	0.43%	1.05%	2.84%	-0.49%	1.87%
FCF Yield	1.73%	1.84%	0.68%	1.04%	-2.81%	-1.31%
Dividend Yield	0.28%	0.24%	0.53%	1.43%	-	1.22%
Payout Ratio	161.10%	187.05%	127.26%	27.54%	-	17.45%
Buyback Yield / Dilution	-3.47%	-4.63%	-0.15%	-1.15%	0.43%	-3.23%
Total Shareholder Return	-3.19%	-4.39%	0.38%	0.28%	0.43%	-2.02%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error